8 names are moving together; 63% are participating in the current session.
Observed intraday paths are not available for this group yet.
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| EXEL | Exelixis, Inc. | Healthcare | -0.8% | Group member |
| ASND | Ascendis Pharma A/S | Healthcare | -2.1% | Group member |
| CM | Canadian Imperial Bank of Comme | Financial Services | -0.4% | Group member |
| IHG | Intercontinental Hotels Group | Consumer Cyclical | -1.7% | Most structurally connected |
| PACS | PACS Group, Inc. | Healthcare | -0.1% | Group member |
| SXT | Sensient Technologies Corporati | Basic Materials | -1.5% | Group member |
| JBIO | Jade Biosciences, Inc. | Healthcare | +1.8% | Group member |
| FDX | FedEx Corporation | Industrials | -0.2% | Group member |
Cohort
8 namesParticipation
63% this sessionObserved history
1 daily buildsFiling coverage
5/8 membersinput costs affecting expense
“Salaries and employee benefit expenses increased 4% in the third quarter and 1% in the nine months of 2026 largely reflecting spin-off-related personnel activity, including the transfer to FedEx Freight of over 1,500 employees from Federal Express during the nine months of 2026, as well as higher wage rates, partially offset by lower volume.”
FDX 10-Q
demand / volume affecting revenue
“Revenue at Corporate, other, and eliminations decreased in the first nine months of 2026 primarily due to lower demand at FedEx Logistics, Inc. (“FedEx Logistics”).”
FDX 10-Q
credit / rates affecting interest expense
“EBITDA – We calculate EBITDA as net income, adjusted for net losses attributable to noncontrolling interest, before: interest expense; provision for income taxes; and depreciation and amortization.”
PACS 10-Q
Cross-asset confirmation is still fragile, so spillover can stall before it becomes durable.
No high-confidence filing-linked non-members are available for this group yet.
Historical cohort observations are not available yet.